RxDoctor Payments Data

Shakirat Oyetunji, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Seattle, WANPI 1700028461

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 66.3% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $15,105, 6.5 times the $2,307 reported in 2019.

$20,534in general payments, 2019–2025

Across 70 payments — averaging $293.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$14K
  • Atricure, Inc.$4K
  • Abbott$2K
  • Medtronic$901
  • Abiomed$24
$34,114in research payments, 2019–2025

Across 14 payments — averaging $2436.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Transmedics, Inc.$28K
  • Medtronic$4K
  • Abbott$3K

What the payments were for

  • Consulting fees$10,90953%
  • Travel & lodging$7,41036%
  • Food & beverage$2,21511%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences32$13,622
Atricure, Inc.18$3,871
Abbott9$2,116
Medtronic(2 entities)10$901
Abiomed1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,534 in reported general payments places this provider in the 80th percentile of 105 thoracic surgery (cardiothoracic vascular surgery) providers in Washington.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Washington

Medicare billing

Part B allowed, 2024
$84,510
Medicare patients
88
Services billed
146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →